Borbély Yves M, Osterwalder Alice, Kröll Dino, Nett Philipp C, Inglin Roman A
Yves M Borbély, Alice Osterwalder, Dino Kröll, Philipp C Nett, Roman A Inglin, Clinic for Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, 3004 Bern, Switzerland.
World J Gastroenterol. 2017 Jul 14;23(26):4689-4700. doi: 10.3748/wjg.v23.i26.4689.
Diarrhea after bariatric procedures, mainly those with malabsorptive elements including Roux-Y Gastric Bypass and Biliopancreatic Diversion, is common and an essential determinant of quality of life and micro- and macronutrient deficiencies. Bariatric surgery is the only sustainably successful method to address morbid obesity and its comorbidities, particularly gaining more and more importance in the specific treatment of diabetic patients. Approximately half a million procedures are annually performed around the world, with numbers expected to rise drastically in the near future. A multitude of factors exert their influence on bowel habits; preoperative comorbidities and procedure-related aspects are intertwined with postoperative nutritional habits. Diagnosis may be challenging owing to the characteristics of post-bariatric surgery anatomy with hindered accessibility of excluded segments of the small bowel and restriction at the gastric level. Conventional testing measures, if available, generally yield low accuracy and are usually not validated in this specific population. Limited trials of empiric treatment are a practical alternative and oftentimes an indispensable part of the diagnostic process. This review provides an overview of causes for chronic post-bariatric surgery diarrhea and details the particularities of its diagnosis and treatment in this specific patient population. Topics of current interest such as the impact of gut microbiota and the influence of bile acids on morbid obesity and especially their role in diarrhea are highlighted in order to provide a better understanding of the specific problems and chances of future treatment in post-bariatric surgery patients.
减肥手术后的腹泻很常见,主要发生在包括Roux-Y胃旁路术和胆胰转流术等具有吸收不良因素的手术之后,它是生活质量以及微量和常量营养素缺乏的重要决定因素。减肥手术是治疗病态肥胖及其合并症的唯一可持续成功的方法,在糖尿病患者的特定治疗中越来越重要。全世界每年大约进行50万例减肥手术,预计在不久的将来数量将大幅上升。多种因素会影响肠道习惯;术前合并症和与手术相关的因素与术后营养习惯相互交织。由于减肥手术后的解剖结构特点,小肠被排除部分难以触及且胃部存在限制,诊断可能具有挑战性。如果有常规检测方法,其准确性通常较低,并且通常未在这一特定人群中得到验证。经验性治疗的有限试验是一种实际的替代方法,而且往往是诊断过程中不可或缺的一部分。本综述概述了减肥手术后慢性腹泻的原因,并详细介绍了这一特定患者群体中腹泻诊断和治疗的特殊性。文中突出了当前感兴趣的主题,如肠道微生物群的影响以及胆汁酸对病态肥胖的影响,特别是它们在腹泻中的作用,以便更好地理解减肥手术后患者的具体问题和未来治疗的机会。